Clinical Trial Update: The Optiflow Patency and Maturation Study [NA]

View source ↗

Summary

Completed clinical trial update for Bioconnect Systems' Optiflow Patency and Maturation Study. The study involved patients with end-stage kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Kidney Disease

Snippet

Sponsor: Bioconnect Systems, Inc | Conditions: End-stage Kidney Disease, End-stage Renal Disease | NA | Status: COMPLETED